Ibrahim Al-khyate։ New Evidence on Triple Antithrombotic Therapy After Anterior Myocardial Infarction
Ibrahim Al-khyate, Cardiology Resident at Ministry of Health and Population – Egypt, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Clinical and Applied Thrombosis/Hemostasis, adding:
”Excited to share our latest publication in Clinical and Applied Thrombosis/Hemostasis!
Our updated systematic review and meta-analysis has now been published in SAGE Journals.
7 studies | 2,273 patients
Research question
Does adding prophylactic triple antithrombotic therapy to dual antiplatelet therapy after anterior myocardial infarction reduce the risk of left ventricular thrombus without compromising patient safety?
Main findings
- No significant reduction in left ventricular thrombus
- No reduction in all-cause mortality
- No reduction in thromboembolic events
Increased risk of major bleeding
Take-home message:
Current evidence does not support the routine use of prophylactic triple antithrombotic therapy after anterior myocardial infarction.
Antithrombotic therapy should be individualized, balancing thrombotic and bleeding risks.
Sincerely grateful to my co-authors and mentors for their dedication, insightful discussions, and collaboration throughout this project.
Looking forward to future collaborations and continuing to contribute to meaningful cardiovascular research.”
Title: Triple Antithrombotic Therapy vs Dual Antiplatelet for Prevention of Left Ventricular Thrombus After Anterior Myocardial Infarction: An Updated Meta-Analysis
Authors: Mustafa Abomohsen, Ibrahim Elkhayat, Ahmed Elmorsy Mohamed, Abdul Hakim Almakadma, Zeyad Kholeif, Ahmed Farid Gadelmawla, Ameer Awashra, Muhammed A. Youssef, Osamah AlQassab, Mohamed Ghannam, Vikas Patel, Azad Mojahedi, Iyad Idries, Meena Farid, Moshe Gunsburg, Hal L. Chadow
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question